These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10808053)

  • 1. Interleukin-12 enhances clinical experimental autoimmune myasthenia gravis in susceptible but not resistant mice.
    Sitaraman S; Metzger DW; Belloto RJ; Infante AJ; Wall KA
    J Neuroimmunol; 2000 Jul; 107(1):73-82. PubMed ID: 10808053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice.
    Balasa B; Deng C; Lee J; Bradley LM; Dalton DK; Christadoss P; Sarvetnick N
    J Exp Med; 1997 Aug; 186(3):385-91. PubMed ID: 9236190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C57BL/6 mice genetically deficient in IL-12/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells.
    Wang W; Milani M; Ostlie N; Okita D; Agarwal RK; Caspi RR; Conti-Fine BM
    J Immunol; 2007 Jun; 178(11):7072-80. PubMed ID: 17513756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease.
    Moiola L; Galbiati F; Martino G; Amadio S; Brambilla E; Comi G; Vincent A; Grimaldi LM; Adorini L
    Eur J Immunol; 1998 Aug; 28(8):2487-97. PubMed ID: 9710226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis.
    Zhang GX; Xiao BG; Bai XF; van der Meide PH; Orn A; Link H
    J Immunol; 1999 Apr; 162(7):3775-81. PubMed ID: 10201893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role for interferon-gamma in rat strains with different susceptibility to experimental autoimmune myasthenia gravis.
    Wang HB; Shi FD; Li H; van der Meide PH; Ljunggren HG; Link H
    Clin Immunol; 2000 May; 95(2):156-62. PubMed ID: 10779409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with Recombinantly Expressed LRP4 Induces Experimental Autoimmune Myasthenia Gravis in C57BL/6 Mice.
    Ulusoy C; Çavuş F; Yılmaz V; Tüzün E
    Immunol Invest; 2017 Jul; 46(5):490-499. PubMed ID: 28375749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of IFN-gamma or IL-12 has different effects on experimental myasthenia gravis in C57BL/6 mice.
    Karachunski PI; Ostlie NS; Monfardini C; Conti-Fine BM
    J Immunol; 2000 May; 164(10):5236-44. PubMed ID: 10799884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal tolerance in experimental autoimmune myasthenia gravis (EAMG): induction of protective tolerance in primed animals.
    Shi FD; Bai XF; Li HL; Huang YM; Van der Meide PH; Link H
    Clin Exp Immunol; 1998 Mar; 111(3):506-12. PubMed ID: 9528890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental autoimmune myasthenia gravis induction in B cell-deficient mice.
    Li H; Shi FD; He B; Bakheit M; Wahren B; Berglöf A; Sandstedt K; Link H
    Int Immunol; 1998 Sep; 10(9):1359-65. PubMed ID: 9786435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production.
    Deng C; Goluszko E; Tüzün E; Yang H; Christadoss P
    J Immunol; 2002 Jul; 169(2):1077-83. PubMed ID: 12097416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal tolerance to experimental autoimmune myasthenia gravis: tolerance reversal by nasal administration of minute amounts of interferon-gamma.
    Li HL; Shi FD; Bai XF; Huang YM; van der Meide PH; Xiao BG; Link H
    Clin Immunol Immunopathol; 1998 Apr; 87(1):15-22. PubMed ID: 9576006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal tolerance to experimental autoimmune myasthenia gravis is associated with down-regulation of AChR-specific IFN-gamma-expressing Th1-like cells and up-regulation of TGF-beta mRNA in mononuclear cells.
    Ma CG; Zhang GX; Xiao BG; Wang ZY; Link J; Olsson T; Link H
    Ann N Y Acad Sci; 1996 Feb; 778():273-87. PubMed ID: 8610980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both CD4+ and CD8+ T cells are essential to induce experimental autoimmune myasthenia gravis.
    Zhang GX; Xiao BG; Bakhiet M; van der Meide P; Wigzell H; Link H; Olsson T
    J Exp Med; 1996 Aug; 184(2):349-56. PubMed ID: 8760788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of interferon-gamma, interleukin-4, and transforming growth factor-beta in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY; Link H; Ljungdahl A; Höjeberg B; Link J; He B; Qiao J; Melms A; Olsson T
    Cell Immunol; 1994 Sep; 157(2):353-68. PubMed ID: 7520837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
    Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH
    J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental autoimmune myasthenia gravis may occur in the context of a polarized Th1- or Th2-type immune response in rats.
    Saoudi A; Bernard I; Hoedemaekers A; Cautain B; Martinez K; Druet P; De Baets M; Guéry JC
    J Immunol; 1999 Jun; 162(12):7189-97. PubMed ID: 10358165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linomide suppresses both Th1 and Th2 cytokines in experimental autoimmune myasthenia gravis.
    Zhang GX; Yu LY; Shi FD; Xiao BG; Björk J; Hedlund G; Link H
    J Neuroimmunol; 1997 Mar; 73(1-2):175-82. PubMed ID: 9058774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular mRNA expression of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) in rats nasally tolerized against experimental autoimmune myasthenia gravis (EAMG).
    Ma CG; Zhang GX; Xiao BG; Link H
    Clin Exp Immunol; 1996 Jun; 104(3):509-16. PubMed ID: 9099937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Th2 cytokine IL-4 is not required for the progression of antibody-dependent autoimmune myasthenia gravis.
    Balasa B; Deng C; Lee J; Christadoss P; Sarvetnick N
    J Immunol; 1998 Sep; 161(6):2856-62. PubMed ID: 9743346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.